General Information
Product name
Saltozon 14 G
Product Synonyms
Diazinon
Chemical name
O,O‐diethyl O‐2‐isopropyl‐6‐methylpyrimidin‐4‐yl
Icons in SDS
Company Information
company name
Agro Chemical Industries LTD (ACI)
e-mail address of the competent person responsible for the Safety Data Sheet
info@aci.com.jo
Section 2
SECTION 2: Hazards identification
Symptoms of Over Exposure May be harmful if swallowed or inhaled. Irritation of eyes, nasal passages, throat and skin. Signs and symptoms include those typical of organophosphate intoxication: Depression of cholinesterase activity, weakness, tightness in chest, headache, blurred vision, non‐reactive pin‐point pupils, nausea, vomiting, diarrhea, abdominal cramps, muscular fibrillation, convulsions, pulmonary edema, possible cardiac arrest and death. Severe intoxication is not likely from this product. Because this formulation contains silica, silicosis (a lung disease) may result. IARC (1987) has concluded there is sufficient evidence for carcinogenicity of crystalline silica in experimental animals, and limited evidence for carcinogenicity in humans Medical Conditions Likely to be Aggravated by Exposure Pre‐existing depressed cholinesterase levels, persons with hemolytic anemias or under treatment with morphine, theophylline, aminophylline or phenothiazine drugs. Pre‐existing lung, kidney, liver or gastrointestinal conditions.
Principle Routes of Exposure
Harmful if ingested, inhaled, or if it comes into contact with eyes or skin. Hazardous Decomposition Products CO, CO2, aliphatic organo‐phosphates, substituted pyrimidines, HCN. S‐ TEPP and diazoxon may form when diazinon is reacted with trace amounts of water. Unusual Fire, Explosion, and Reactivity Hazards Dusts may present explosion hazard.
